CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer

@article{Molina2011CA1I,
  title={CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer},
  author={V{\'i}ctor D{\'i}az Molina and Laura Visa and Carles Conill and Salvador Zamora Navarro and Jos{\'e} Vicente Maeso Escudero and Jose Maria Auge and Xavier Filella and Miguel Angel L{\'o}pez-Boado and Joana Ferrer and Laureano Fern{\'a}ndez-Cruz and Rafael I. Molina},
  journal={Tumor Biology},
  year={2011},
  volume={33},
  pages={799-807}
}
CA 19.9 serum levels were prospectively determined in 573 patients admitted to hospital for suspicion of pancreatic cancer. The final diagnosis was 77 patients with no malignancy, 389 patients with pancreatic cancer, 37 neuroendocrine pancreatic cancer, 28 cholangiocarcinomas, 4 gallbladder cancer, 27 ampullary carcinomas, and 11 periampullary carcinomas. CA 19.9 was determined using a commercial assay from Roche Diagnostics, and 37 U/ml was considered as the upper limit of normality. Abnormal… CONTINUE READING